Patent Yard Sign in
Canadian application, no grantCanada

A transurethral device

CA 2291612 A1 · Owner: Astra Aktiebolag · Inventors: Eek, Arne

CIPO record

Overview

Drawings and full text

Its claims, description and drawings are in the Canadian Patents Database.

Open the CIPO record

Abstract From the Canadian patent

A transurethral device (10) for delivery of a drug to the urethra of a human or animal body comprising a drug carrying element (3) which presents an elongate shaft (9) having a free forward end for insertion into the urethra of the human or animal body in a forward direction the elongate shaft being , provided with a channel (15) having an opening (17) in the outer surface of the elongate shaft for transport of the drug to the urethra. The device further comprises means (5, 30) adapted to draw a dose of the drug into the channel from a fluid supply of the drug. The device may further comprise a sheath (7) for releasably sheathing at least the insertable length of the elongate shaft …

Read the whole patent

Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.

Why it's free to use

  • Filed May 29, 1998. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended May 29, 2018.
  • A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by May 29, 2020.
  • We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledMay 29, 1998
GrantedNo grant recorded
Term endedMay 29, 2018
Patent numberCA 2291612 A1
Classification (IPC)A61M31/00 +2 more

Timeline

Timeline From CIPO dates

1999200120032005200720092011201320152017Application filedMay 29, 1998Term endedMay 29, 2018

Sources & verification

Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.